Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Apoiando mães em risco durante o período perinatal (SMART)

11 de novembro de 2026 atualizado por: Shefaly Shorey, National University of Singapore

Apoiando mães em risco durante o período perinatal: um ensaio clínico randomizado

The SMART app is a mobile application based psychosocial parenting intervention containing educational materials (articles, videos, audios, podcasts) on parenting, an integrated peer support chat function with experienced mothers and an integrated forum for interaction with other mother participants.

The goal of this interventional study is to test the effectiveness of a mobile-app health based intervention, SMART, mothers in the perinatal period.

The main questions this study aims to answer are:

  1. What is the effect of a mobile-based health intervention, SMART, on maternal outcomes?
  2. What is the effect of a mobile-based health intervention, SMART, on infant outcomes?
  3. What is the cost-effectiveness of using SMART as compared to standard routine care?

Researchers will compare results with a control group that will undergo standard routine care.

Visão geral do estudo

Descrição detalhada

This project aims to develop and evaluate a mobile-health application based Supporting at-risk Mothers across perinatal period: A Randomized controlled Trial (SMART) intervention on maternal outcomes such as maternal depression, anxiety and stress, parenting self-efficacy, help-seeking behaviour and attachment and interaction levels , newborn outcomes such as physical, social and emotional development as well as the cost-effectiveness of the intervention.

When compared with those in the control group receiving standard care:

  1. mothers receiving SMART intervention will have better: i) emotional well-being (reduced depression, stress, and anxiety); ii) parenting self-efficacy; iii) social support; and iv) attachment, interactions with their newborns and parenting satisfaction.
  2. newborns of mothers receiving SMART will have better: i) physical development; ii) social development; and iii) emotional development.
  3. It will be more cost-effective to provide SMART than the standard care.

A randomized controlled, two-group pre-test and repeated post-tests, experimental design will be used. Mothers will be randomly assigned to the intervention group, where they will receive the SMART intervention (Access to the mobile App from pregnancy till 6 months postpartum) which includes knowledge-based content with audio and video materials, a peer discussion forum with other mothers, online chat groups with peer volunteer who are experienced mothers plus the standard care. Peer volunteers will be recruited and their role is to provide support to the mother via a weekly chat with the mothers through the SMART application. The control group will receive the standard care provided by the hospitals and polyclinics. The effectiveness of SMART intervention will be measured based on the improvement of maternal depression (primary outcome), stress and anxiety, parenting self-efficacy in newborn care, social support received by mothers, mother-infant attachment, and interactions as well as newborn outcomes including physical, behavioral (social) and emotional development.

Newborn data such as baby gender, order of birth, baby weight and developmental milestones will be collected to examine their development.

Tipo de estudo

Intervencional

Inscrição (Estimado)

200

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

      • Singapore, Cingapura, 117597
        • National University of Singapore
    • Singapore
      • Singapore, Singapore, Cingapura, 117597
        • Alice Lee Centre for Nursing Studies, National University of Singapore

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

21 anos a 65 anos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Sim

Gêneros Elegíveis para o Estudo

Fêmea

Descrição

Inclusion Criteria:

  • mothers who (1) are 21 years old to 65 years old; (2) can read and speak English; (3) belong to a vulnerable population due to one or more of the following criteria: i) monthly household income is =/less than SGD 2500 and/or under any low-income support services (referral from social workers) ii) have positive maternal Adverse Childhood Events (ACES) evaluation; iii) single mother; iv) clinically referred by medical professionals or other allied workers for requiring psychosocial support; v) pregnancy or birth of baby diagnosed with congenital malformation/abnormality where baby is 1 year old or less and can be discharged home with mother; vi) mothers with Edinburgh Postnatal Depression Scores (EPDS) =9 (at-risk for depression); and (4) have a smartphone with internet access.

Exclusion Criteria:

  • mothers who (1) have chronic physical or mental disorders which would interfere with their ability to participate in the study, and/or (2) gave birth to a baby who needs prolonged hospitalization or NICU support and /or stillborn (3) has a cognitive impairment

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Cuidados de suporte
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Mothers using SMART app

The intervention will be delivered via a mobile-based application, the SMART app. The intervention consists of educational material on parenting, pregnancy and managing emotional well-being that mothers are to engage in. Mothers will also participate in the forum with other mother participants. Mothers will also engage in the chat function with a peer volunteer who is an experienced mother. The app is accessible to the mother via the Android or iOS playstore and mother can access anytime in their convenience over 6 months.

The intervention is delivered through the SMART mobile application. It contains educational information in audio, visual, article format; on parenting, pregnancy and managing emotional well-being. There is also a peer support feature where participants can speak to experienced mothers via the SMART app. There is also a forum feature where participants can interact with other mothers.

Sem intervenção: Standard Care

This includes routine perinatal visits and check-ups at the hospital or polyclinic the mother is assigned to.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Postnatal depression
Prazo: Baseline and 6 month, 9month, 12month post childbirth

Measured via the Edinburgh Postnatal Depression Scale, a 10-item self-reported questionnaire based on a 4-point Likert scale

Baseline and 6 month, 9month, 12month post childbirth

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Infant physical development
Prazo: 1 month and 6 month at immediate post intervention

Measured via the Bayley Scale-4th edition

1 month and 6 month at immediate post intervention
Infant cognitive development
Prazo: 1 month and 6 month at immediate post intervention

Measured via the Bayley Scale-4th edition

1 month and 6 month at immediate post intervention
Infant emotional development
Prazo: 1 month and 6 month at immediate post intervention

Measured via the Bayley Scale-4th edition

1 month and 6 month at immediate post intervention
Anxiety
Prazo: Baseline and 6 month, 9month, 12month post childbirth

Measured via the State Trait Anxiety Inventory (STAI), a 40-item self-reported questionnaire based on a 4-point Likert scale

Baseline and 6 month, 9month, 12month post childbirth
Perceived stress
Prazo: Baseline and 6 month, 9month, 12month post childbirth

Measured via the Perceived Stress Scale-10 (PSS-10), a 10-item self-reported questionnaire on a 5 point Likert scale

Baseline and 6 month, 9month, 12month post childbirth
Perceived social support
Prazo: Baseline and 6 month, 9month, 12month post childbirth

Measured via the Perceived Social Support for Parenting (PSSP), a 10-item questionnaire on a 5-point Liker scale

Baseline and 6 month, 9month, 12month post childbirth
Maternal-infant bonding
Prazo: 1 month, 6 month, 9 month and 12 month post childbirth

Measured via the Maternal-Infant Bonding Scale (MIBS), an 8-item self-reported questionnaire on a 4-point Likert scale

1 month, 6 month, 9 month and 12 month post childbirth
Parental satisfaction
Prazo: Baseline and 6 month, 9month, 12month post childbirth

Measured via the What Being the Parent of A Baby is Like (WPL), an 11-item self-reported questionnaire on a 9-point Likert scale

Baseline and 6 month, 9month, 12month post childbirth
Parental efficacy
Prazo: Baseline and 6 month, 9month, 12month post childbirth

Measured via a 10-item questionnaire on a 4-point Likert scale

Baseline and 6 month, 9month, 12month post childbirth
Objective stress
Prazo: 1 month and 6 month at immediate post intervention

Measured via salivary cortisol biomarkers obtained through saliva samples

1 month and 6 month at immediate post intervention
Emotional availability
Prazo: 1 month and 6 month at immediate post intervention

Measured through the Emotional Availability Scale (EAS), a 5-dimension framework assessing both the parent and the infant via an observer.

1 month and 6 month at immediate post intervention
Health services and utilization
Prazo: Baseline, 1 month, 6 month and 12month post childbirth

Measured on the Questionnaire on health services and utilization (QHSU)

Baseline, 1 month, 6 month and 12month post childbirth
Infant Physical Development
Prazo: 1 month, 6 month, 9 month and 12 month post childbirth

Measured by the Ages and Stages Questionnaire-3

1 month, 6 month, 9 month and 12 month post childbirth
Infant Social Development
Prazo: 1 month, 6 month, 9 month, 12 month post childbirth

Measured by the Ages and Stages Questionnaire-3

1 month, 6 month, 9 month, 12 month post childbirth
Infant Social Development
Prazo: 12 month post childbirth

Measured by the Brief-Infant and Toddle Social and Emotional Assessment (B-ITSEA)

12 month post childbirth
Infant Social Development
Prazo: 1 month and 6 month at immediate post intervention

Measured by the Bayley Scale-4th edition

1 month and 6 month at immediate post intervention
Infant Emotional Development
Prazo: 12 month post childbirth

Measured by the Brief Infant Toddler Social Emotional Assessment (B-ITSEA)

12 month post childbirth

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Investigadores

  • Investigador principal: Shefaly Shorey, PhD, National University of Singapore

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

26 de fevereiro de 2024

Conclusão Primária (Real)

7 de janeiro de 2026

Conclusão do estudo (Estimado)

30 de dezembro de 2026

Datas de inscrição no estudo

Enviado pela primeira vez

9 de março de 2024

Enviado pela primeira vez que atendeu aos critérios de CQ

9 de abril de 2024

Primeira postagem (Real)

12 de abril de 2024

Atualizações de registro de estudo

Última Atualização Postada (Real)

16 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

11 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • 2023/00158
  • 2023 (Concessão/Contrato do NIH dos EUA)

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever